Vision-Sciences Appoints Howard Zauberman as Interim Chief Executive Officer

Vision-Sciences Appoints Howard Zauberman as Interim Chief Executive Officer

ORANGEBURG, N.Y., May 13, 2013 (GLOBE NEWSWIRE) -- Vision-Sciences, Inc.
(Nasdaq:VSCI), a leading provider of unique flexible endoscopic products
utilizing its proprietary sterile disposable EndoSheath® technology, today
announced that Howard I. Zauberman has been named as Interim Chief Executive
Officer, effective immediately.

Mr. Zauberman replaces Cynthia Ansari, who stepped down as Chief Executive
Officer and President.

Mr. Zauberman, 60, has over 30 years of experience as a leader in the medical
products industry. Prior to joining the Company, Mr. Zauberman was Vice
President of Business Development at Henry Schein, Inc., a leading global
healthcare distributor serving office based medical practitioners, from 2005
through 2012. Mr. Zauberman also served as a Special Venture Partner at Galen
Partners, a healthcare growth equity and late stage venture capital firm,
focused on technology enabled services, medical devices and specialty
pharmaceuticals. Prior to this, Mr. Zauberman held senior management positions
at ETHICON, Inc. a Johnson & Johnson company and Pfizer, Inc.Mr. Zauberman
has a Masters of Engineering Management from Northwestern University, a
Bachelor of Science from Columbia University in mechanical engineering and a
Bachelors degree from Queens College.

"Howard is an experienced executive with strong business development
experience and deep knowledge of the medical device business," said Mr. Lewis
Pell, Chairman of the Board.

Mr. Pell continued, "The appointment of Mr. Zauberman reflects the Board's
determination to assist the Company in fully realizing its commercial
potential." Mr. Pell added, "I want to assure the stockholders of
Vision-Sciences that the Company is committed to achieving its financial
goals."

Mr. Zauberman said, "I am honored by the Board's decision and the confidence
they have placed in me, and I look forward to working with the outstanding
team of people at Vision-Sciences and our partners and doctors. The Company is
in an exciting stage of its development and I am enthusiastic about the
opportunity to lead the organization."

A special committee of the Board, composed of independent directors, has
initiated the search for a new chief executive officer.

About Vision-Sciences, Inc.

Vision-Sciences, Inc. designs, develops, manufactures and markets products for
flexible endoscopy. The company's unique product lines feature a streamlined
visualization system and proprietary sterile disposable microbial barrier,
known as EndoSheath technology, providing users with efficient and cost
effective endoscope turnover while enhancing patient safety.Currently,
Vision-Sciences offers solutions for five main healthcare areas: urology,
pulmonology (critical care), gastroenterology (GI), ENT (ear, nose and throat)
and spine. Information about Vision-Sciences' products is available at
www.visionsciences.com.

Vision Sciences^®, Slide-On^®, EndoSheath^®, EndoWipe^® and The Vision
System^® are registered trademarks of Vision-Sciences, Inc.

The Vision-Sciences, Inc. logo is available at
http://www.globenewswire.com/newsroom/prs/?pkgid=3876

CONTACT: Keith Darragh
         VP, Finance and Principal Financial and Accounting Officer
         Vision-Sciences, Inc.
         (845) 365-0600
         invest@visionsciences.com
        
         Lisa Wilson
         President
         In-Site Communications, Inc.
         (212) 452-2793
         lwilson@insitecony.com

company logo
 
Press spacebar to pause and continue. Press esc to stop.